Literature DB >> 10070878

The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.

L E Gerweck1, S V Kozin, S J Stocks.   

Abstract

The accumulation and toxicity of the weak base doxorubicin has been investigated as a function of extracellular pH, intracellular pH and the cellular pH gradient in cells previously cultured under normal (pH 7.4) and low-pH (6.8) conditions. Low-pH-adapted cells exhibit transmembrane pH gradients which substantially differ from normal cells at the same extracellular pH. No relationship was obtained between intracellular pH and the uptake or toxicity of doxorubicin in the two cell types. In contrast, doxorubicin accumulation and toxicity increased with increasing extracellular pH in both normal and low-pH-adapted cells. However, at the same extracellular pH, drug cytotoxicity was more pronounced in normal than in low-pH-adapted cells. The difference in doxorubicin accumulation and cytotoxicity at the same extracellular pH was found to be dependent on the difference in the transmembrane pH gradient of the two cell types. As the cellular pH gradient differs between tumour and normal tissue, this observation suggests a basis for enhancing cellular drug uptake in either tissue type.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070878      PMCID: PMC2362684          DOI: 10.1038/sj.bjc.6690134

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  The role of low intracellular or extracellular pH in sensitization to hyperthermia.

Authors:  G L Chu; W C Dewey
Journal:  Radiat Res       Date:  1988-04       Impact factor: 2.841

2.  Influence of pH on the cytotoxic activity of chlorambucil.

Authors:  G T Brophy; N E Sladek
Journal:  Biochem Pharmacol       Date:  1983-01-01       Impact factor: 5.858

3.  The anticancer agent adriamycin can be actively cytotoxic without entering cells.

Authors:  T R Triton; G Yee
Journal:  Science       Date:  1982-07-16       Impact factor: 47.728

4.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

Authors:  G Noel; C Peterson; A Trouet; P Tulkens
Journal:  Eur J Cancer       Date:  1978-04       Impact factor: 9.162

Review 5.  Intracellular pH.

Authors:  A Roos; W F Boron
Journal:  Physiol Rev       Date:  1981-04       Impact factor: 37.312

6.  Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil.

Authors:  R B Mikkelsen; C Asher; T Hicks
Journal:  Biochem Pharmacol       Date:  1985-07-15       Impact factor: 5.858

7.  Influence of extracellular pH on intracellular pH and cell energy status: relationship to hyperthermic sensitivity.

Authors:  M P Fellenz; L E Gerweck
Journal:  Radiat Res       Date:  1988-11       Impact factor: 2.841

8.  Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro.

Authors:  E Jähde; K H Glüsenkamp; I Klünder; D F Hülser; L F Tietze; M F Rajewsky
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

9.  Cellular uptake of misonidazole and analogues with acidic or basic functions.

Authors:  M F Dennis; M R Stratford; P Wardman; M E Watts
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1985-06

10.  Effect of different physiological conditions on the action of adriamycin on Chinese hamster cells in vitro.

Authors:  R Born; H Eichholtz-Wirth
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  17 in total

1.  Label-Free in Situ pH Monitoring in a Single Living Cell Using an Optical Nanoprobe.

Authors:  Qingbo Yang; Xiaobei Zhang; Yang Song; Ke Li; Honglan Shi; Hai Xiao; Yinfa Ma
Journal:  Med Devices Sens       Date:  2020-03-12

2.  Dynamic analysis of metabolic effects of chloroacetaldehyde and cytochalasin B on tumor cells using bioelectronic sensor chips.

Authors:  E R Motrescu; A M Otto; M Brischwein; S Zahler; B Wolf
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

3.  Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development.

Authors:  D J Adams; L R Morgan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 4.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 5.  Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.

Authors:  Erwin G Van Meir; Binghe Wang; Sarah K Burroughs; Stefan Kaluz; Danzhu Wang; Ke Wang
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

6.  A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.

Authors:  Luoping Zhai; Chuangwei Luo; Hannan Gao; Shuaifan Du; Jiyun Shi; Fan Wang
Journal:  Int J Nanomedicine       Date:  2021-05-10

Review 7.  Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 2: Functional and Molecular Properties of ASOR/PAC Channels and Their Roles in Cell Volume Dysregulation and Acidotoxic Cell Death.

Authors:  Yasunobu Okada; Kaori Sato-Numata; Ravshan Z Sabirov; Tomohiro Numata
Journal:  Front Cell Dev Biol       Date:  2021-07-09

8.  Hypoxia in head and neck squamous cell carcinoma.

Authors:  John Zenghong Li; Wei Gao; Jimmy Yu-Wai Chan; Wai-Kuen Ho; Thian-Sze Wong
Journal:  ISRN Otolaryngol       Date:  2012-10-16

Review 9.  The chemistry, physiology and pathology of pH in cancer.

Authors:  Pawel Swietach; Richard D Vaughan-Jones; Adrian L Harris; Alzbeta Hulikova
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

10.  Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin.

Authors:  Pawel Swietach; Alzbeta Hulikova; Shalini Patiar; Richard D Vaughan-Jones; Adrian L Harris
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.